---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-026238"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2021-10-25T23:59:59+00:00"
generated_at: "2026-06-28T18:25:38.409312+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Integrity Applications appoints Paul Goode as President and COO effective Nov 1, 2021

## Summary
- Paul V. Goode appointed President and COO effective November 1, 2021; steps down from Board.
- Base salary of $175,000/year; eligible for cash bonus up to 20% of base salary.
- Granted options to purchase 1.5% of fully diluted common stock at exercise price ≥ $5.20, vesting over 3 years.
- Goode most recently VP of Product Development at Orchestra Biomed; will lead U.S. infrastructure for GlucoTrack trials.
- Employment agreement includes standard termination provisions and financial-misstatement clawback.

## SEC filing metadata
- accession: 0001493152-21-026238
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2021-10-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/0001493152-21-026238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-026238
- JSON: https://secwatch.observer/filing/0001493152-21-026238.json
- Plain text: https://secwatch.observer/filing/0001493152-21-026238.txt

## Key facts
- Executive change
  Paul V. Goode was appointed as President and Chief Operating Officer at Glucotrack, Inc..
  - Action: appointed
  - Role: President and Chief Operating Officer
  source text: On October 19, 2021, Paul V. Goode was appointed as President and Chief Operating Officer of Integrity Applications, Inc. (the “Company”), effective November 1, 2021 (“Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/0001493152-21-026238-index.htm
- Executive change
  Paul V. Goode departed as Director at Glucotrack, Inc..
  - Action: stepping down
  - Role: Director
  source text: Concurrent with his new appointment, Mr. Goode will be stepping down from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/0001493152-21-026238-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.